Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
ICD-10 N05.5 is a billable code used to indicate a diagnosis of unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis.
Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis is characterized by a combination of nephritic syndrome symptoms, including hematuria, proteinuria, and hypertension, alongside the histological findings of diffuse mesangiocapillary glomerulonephritis. This condition often presents with varying degrees of renal impairment and can be associated with systemic diseases such as infections, autoimmune disorders, or can be idiopathic. The diffuse mesangiocapillary pattern is noted for its proliferation of mesangial cells and thickening of the capillary walls, which can lead to significant protein leakage into the urine. Diagnosis typically involves renal biopsy, which reveals the characteristic histological changes. Management may include corticosteroids, immunosuppressants, and supportive care aimed at controlling blood pressure and proteinuria. The prognosis can vary widely depending on the underlying cause and the response to treatment.
Detailed renal function tests, biopsy results, and treatment plans must be documented.
Patients presenting with hematuria and proteinuria, requiring renal biopsy for diagnosis.
Ensure clarity in distinguishing between nephritic and nephrotic syndromes in documentation.
Comprehensive history and physical examination, including systemic symptoms and laboratory results.
Management of patients with renal impairment and systemic symptoms suggestive of nephritic syndrome.
Document any comorbid conditions that may affect renal function.
When a renal biopsy is performed to confirm the diagnosis of nephritic syndrome.
Document indications for biopsy, findings, and any complications.
Nephrology specialists should ensure that the biopsy results are clearly linked to the diagnosis.
The primary treatment for unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis often includes corticosteroids and immunosuppressive agents, along with management of hypertension and proteinuria.
